Limited spots remain for the ATN Innovation Summit.
Secure your spot and join 750+ industry executives on June 16 & 17 in NYC.
Noom’s microdose GLP-1 program says 70% of users report no side effects and lose up to 17 pounds in 60 days with behavior change support.
Longevity-focused telehealth platform Ageless Rx has added oral GLP-1 drops as a needle-free option for weight loss consumers.
Found has launched affordable oral weight loss pills, but a groundbreaking drug-free solution is on the horizon from biomed company Epitomee.
WeightWatchers is making potatoes OK again as the storied weight management company leans into compounded GLP-1s, AI and B2B.
Digital healthcare platform Noom is launching oral weight loss medication, beginning with FDA-approved Metformin.
As GLP-1 drugs surge, here's how telehealth companies and brick-and-mortar fitness giants are responding to the Ozempic era.
Noom has partnered with Prism Labs to give GLP-1 users a way to monitor and track body composition and muscle mass.
The rising interest in fitness and health has led gym membership and engagement numbers to soar across low-priced, high-value franchises
Zumba instructors can gain an edge by becoming Noom Mindset Coaches as the dance-fitness brand continues to expand its reach.
A new market has emerged which focuses on maintaining the lean muscle mass of consumers taking weight-loss drugs like Ozempic.
Sign Up to Our Newsletter
